TP53 and acute lymphoblastic leukemia: For further analysis of p53 functionality, we selected two MLLr BCP-ALL PDXs exhibiting p53-associated aberrations, one with MDM2 overexpression (PDX#4) and the other showing no TP53 expression (PDX#5).